2020 Q1 Form 10-K Financial Statement
#000156459020011636 Filed on March 18, 2020
Income Statement
| Concept | 2020 Q1 | 2019 Q4 | 2019 Q3 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $2.920M | $2.420M | $1.520M |
| YoY Change | 461.54% | 236.11% | 204.0% |
| % of Gross Profit | |||
| Research & Development | $7.778M | $7.190M | $6.680M |
| YoY Change | 80.46% | 94.85% | 103.1% |
| % of Gross Profit | |||
| Depreciation & Amortization | $12.00K | $10.00K | $0.00 |
| YoY Change | 300.0% | 0.0% | |
| % of Gross Profit | |||
| Operating Expenses | $10.70M | $9.610M | $8.198M |
| YoY Change | 121.48% | 117.91% | 116.53% |
| Operating Profit | -$10.70M | -$9.611M | -$8.198M |
| YoY Change | 121.48% | 118.04% | 116.53% |
| Interest Expense | |||
| YoY Change | |||
| % of Operating Profit | |||
| Other Income/Expense, Net | $157.0K | -$9.540M | -$10.47M |
| YoY Change | -62.26% | 4670.0% | 2662.53% |
| Pretax Income | -$10.55M | -$19.15M | -$18.67M |
| YoY Change | 138.79% | 315.4% | 348.21% |
| Income Tax | -$1.000K | $130.0K | $57.00K |
| % Of Pretax Income | |||
| Net Earnings | -$10.54M | -$19.28M | -$18.73M |
| YoY Change | 137.53% | 315.76% | 349.58% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$764.3K | -$1.398M | -$1.553M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 13.79M | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2020 Q1 | 2019 Q4 | 2019 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $85.50M | $93.30M | $16.20M |
| YoY Change | |||
| Cash & Equivalents | $85.53M | $93.34M | $16.23M |
| Short-Term Investments | |||
| Other Short-Term Assets | $1.900M | $2.000M | $400.0K |
| YoY Change | |||
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $87.40M | $95.33M | $16.59M |
| YoY Change | 742.4% | ||
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $200.0K | $155.0K | $49.00K |
| YoY Change | 369.7% | ||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $72.00K | $72.00K | $1.700M |
| YoY Change | |||
| Total Long-Term Assets | $289.0K | $227.0K | $1.766M |
| YoY Change | 328.3% | ||
| TOTAL ASSETS | |||
| Total Short-Term Assets | $87.40M | $95.33M | $16.59M |
| Total Long-Term Assets | $289.0K | $227.0K | $1.766M |
| Total Assets | $87.69M | $95.55M | $18.35M |
| YoY Change | 740.47% | ||
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $4.055M | $989.0K | $3.571M |
| YoY Change | -34.46% | ||
| Accrued Expenses | $3.732M | $4.620M | $2.992M |
| YoY Change | 293.86% | ||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $7.787M | $5.600M | $22.58M |
| YoY Change | 28.65% | ||
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $7.787M | $5.600M | $22.58M |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $7.800M | $5.600M | $22.60M |
| YoY Change | |||
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$84.14M | -$73.60M | -$54.31M |
| YoY Change | 354.97% | ||
| Common Stock | $164.0M | $163.5M | $342.0K |
| YoY Change | 137328.57% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $79.90M | $89.94M | -$53.97M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $87.69M | $95.55M | $18.35M |
| YoY Change | 740.47% |
Cashflow Statement
| Concept | 2020 Q1 | 2019 Q4 | 2019 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$10.54M | -$19.28M | -$18.73M |
| YoY Change | 137.53% | 315.76% | 349.58% |
| Depreciation, Depletion And Amortization | $12.00K | $10.00K | $0.00 |
| YoY Change | 300.0% | 0.0% | |
| Cash From Operating Activities | -$7.752M | -$11.13M | -$6.200M |
| YoY Change | 86.03% | 238.3% | 144.09% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $61.00K | -$110.0K | -$10.00K |
| YoY Change | 2950.0% | 0.0% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$61.00K | -$110.0K | -$10.00K |
| YoY Change | 2950.0% | 0.0% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 9.000K | 88.37M | 490.0K |
| YoY Change | 881.89% | ||
| NET CHANGE | |||
| Cash From Operating Activities | -7.752M | -11.13M | -6.200M |
| Cash From Investing Activities | -61.00K | -110.0K | -10.00K |
| Cash From Financing Activities | 9.000K | 88.37M | 490.0K |
| Net Change In Cash | -7.804M | 77.13M | -5.720M |
| YoY Change | 87.19% | 1250.79% | 124.31% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$7.752M | -$11.13M | -$6.200M |
| Capital Expenditures | $61.00K | -$110.0K | -$10.00K |
| Free Cash Flow | -$7.813M | -$11.02M | -$6.190M |
| YoY Change | 87.41% | 234.95% | 144.66% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
| CY2019 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2019 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2019 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
| CY2019 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2019 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2019 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
| CY2019 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
| CY2019 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
| CY2019 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
| CY2019 | dei |
Security12b Title
Security12bTitle
|
Common stock, par value $0.001 per share | |
| CY2019 | dei |
Trading Symbol
TradingSymbol
|
ETNB | |
| CY2019 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
| CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
93335000 | |
| CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11234000 | |
| CY2019Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
25000 | |
| CY2018Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
23000 | |
| CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
59000 | |
| CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11316000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
20000 | |
| CY2018Q4 | etnb |
Convertible Preferred Stock Liability
ConvertiblePreferredStockLiability
|
1671000 | |
| CY2018Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
23073000 | |
| CY2019Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
| CY2018Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
| CY2019Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
0 | |
| CY2018Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
60000000 | |
| CY2019Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | |
| CY2018Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
24000000 | |
| CY2019Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | |
| CY2018Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
24000000 | |
| CY2019Q4 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
0 | |
| CY2018Q4 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
24000000 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2019 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
24.49 | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
36.45 | ||
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | |
| us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
11000 | ||
| us-gaap |
Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
|
0 | ||
| etnb |
Temporary Equity Conversion Of Convertible Note In To Preferred Shares Value
TemporaryEquityConversionOfConvertibleNoteInToPreferredSharesValue
|
0 | ||
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
108000 | ||
| CY2019 | us-gaap |
Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
|
0 | |
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
| CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2020Q1 | dei |
Entity Public Float
EntityPublicFloat
|
169328521000000 | |
| CY2020Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
13788982 | |
| CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10415900 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
13788982 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
611226 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
13788982 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
611226 | |
| CY2019 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
21346000 | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
13681000 | ||
| CY2019 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5294000 | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1481000 | ||
| CY2019 | us-gaap |
Operating Expenses
OperatingExpenses
|
26640000 | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
15162000 | ||
| CY2019 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-57202000 | |
| CY2019 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
218000 | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
28000 | ||
| CY2019 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-57420000 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-16176000 | ||
| CY2019 | etnb |
Conversion Of Convertible Preferred Stock Into Common Stock At Initial Public Offering
ConversionOfConvertiblePreferredStockIntoCommonStockAtInitialPublicOffering
|
49746000 | |
| CY2019 | etnb |
Property And Equipment Purchases Included In Accounts Payable
PropertyAndEquipmentPurchasesIncludedInAccountsPayable
|
55000 | |
| CY2019 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
87691000 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
107702000 | |
| CY2019 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
49746000 | |
| CY2019 | etnb |
Capital Contribution Related To Extinguishment Of Preferred Stock Liability
CapitalContributionRelatedToExtinguishmentOfPreferredStockLiability
|
25595000 | |
| CY2019 | etnb |
Stock Issued During Period Issuance Costs
StockIssuedDuringPeriodIssuanceCosts
|
3083000 | |
| CY2019 | us-gaap |
Profit Loss
ProfitLoss
|
-57420000 | |
| us-gaap |
Profit Loss
ProfitLoss
|
-16176000 | ||
| CY2019 | us-gaap |
Depreciation
Depreciation
|
17000 | |
| us-gaap |
Depreciation
Depreciation
|
6000 | ||
| CY2019 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
389000 | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
108000 | ||
| CY2019 | etnb |
Deferred Tax Assets
DeferredTaxAssets
|
-20000 | |
| etnb |
Deferred Tax Assets
DeferredTaxAssets
|
20000 | ||
| CY2019 | etnb |
Revaluation Of Convertible Preferred Stock Liability
RevaluationOfConvertiblePreferredStockLiability
|
30597000 | |
| etnb |
Revaluation Of Convertible Preferred Stock Liability
RevaluationOfConvertiblePreferredStockLiability
|
979000 | ||
| CY2019 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1918000 | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
48000 | ||
| CY2019 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
72000 | |
| CY2019 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-520000 | |
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1509000 | ||
| CY2019 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
3447000 | |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1173000 | ||
| CY2019 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-25460000 | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-12469000 | ||
| CY2019 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
139000 | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
39000 | ||
| CY2019 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-139000 | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-39000 | ||
| CY2019 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
20000000 | |
| us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
23665000 | ||
| CY2019 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
11000 | |
| us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
100000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
23765000 | ||
| CY2019 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
82103000 | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
11257000 | ||
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11257000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
93360000 | |
| CY2019Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
25000 | |
| CY2018Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
23000 | |
| etnb |
Conversion Of Convertible Note Into Preferred Stock
ConversionOfConvertibleNoteIntoPreferredStock
|
100000 | ||
| CY2019 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
106000 | |
| CY2019 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to the fair value of stock options, the convertible preferred stock liability and certain accruals. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</p> | |
| CY2019 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial<font style="letter-spacing:0.05pt;"> </font>instruments<font style="letter-spacing:0.1pt;"> </font>that<font style="letter-spacing:0.05pt;"> </font>potentially<font style="letter-spacing:0.1pt;"> </font>subject<font style="letter-spacing:0.05pt;"> </font>the Company to a concentration<font style="letter-spacing:0.1pt;"> </font>of credit<font style="letter-spacing:0.05pt;"> </font>risk<font style="letter-spacing:0.05pt;"> </font>consist primarily<font style="letter-spacing:0.1pt;"> </font>of cash and cash equivalents.<font style="letter-spacing:0.1pt;"> </font>Bank<font style="letter-spacing:-0.05pt;"> </font>deposits<font style="letter-spacing:0.05pt;"> </font>are held by accredited<font style="letter-spacing:0.1pt;"> </font>financial<font style="letter-spacing:0.1pt;"> </font>institutions<font style="letter-spacing:0.1pt;"> </font>and these deposits<font style="letter-spacing:0.05pt;"> </font>may at times<font style="letter-spacing:0.05pt;"> </font>be in excess<font style="letter-spacing:0.05pt;"> </font>of insured<font style="letter-spacing:0.05pt;"> </font>limits. The Company limits<font style="letter-spacing:0.1pt;"> </font>its<font style="letter-spacing:0.05pt;"> </font>credit<font style="letter-spacing:0.05pt;"> </font>risk<font style="letter-spacing:0.05pt;"> </font>associated<font style="letter-spacing:0.1pt;"> </font>with cash and cash equivalents<font style="letter-spacing:0.1pt;"> </font>by placing<font style="letter-spacing:0.05pt;"> </font>them<font style="letter-spacing:0.05pt;"> </font>with financial<font style="letter-spacing:0.1pt;"> </font>institutions<font style="letter-spacing:0.1pt;"> </font>that<font style="letter-spacing:0.05pt;"> </font>it believes<font style="letter-spacing:0.05pt;"> </font>are of high quality.<font style="letter-spacing:0.05pt;"> </font>The Company has not experienced<font style="letter-spacing:0.05pt;"> </font>any losses<font style="letter-spacing:0.05pt;"> </font>on its<font style="letter-spacing:0.05pt;"> </font>deposits<font style="letter-spacing:0.05pt;"> </font>of cash or cash equivalents. </p> | |
| CY2019 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
178000 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
39000 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
23000 | |
| CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6000 | |
| CY2019Q4 | etnb |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
2326000 | |
| CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1396000 | |
| CY2019Q4 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
On October 24, 2019, 89bio, Inc.’s board of directors approved an amendment to the amended and restated certificate of incorporation of 89bio, Inc. to effect a 1 for 6.217 reverse split (“Reverse Split”) of shares of the common stock of 89bio, Inc. and a proportional adjustment to the conversion ratio of the convertible preferred stock, which was effected on October 25, 2019. | |
| CY2019Q4 | etnb |
Reverse Stock Split Date
ReverseStockSplitDate
|
2019-10-25 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
| CY2019Q4 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
3100000 | |
| CY2019 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2019-06-28 | |
| CY2019 | etnb |
Reorganization Exchange Of Equity Percentage Of Common Stock Issued Upon Exchange
ReorganizationExchangeOfEquityPercentageOfCommonStockIssuedUponExchange
|
1.00 | |
| CY2019 | etnb |
Reorganization Exchange Of Equity Percentage Of Ordinary Shares Exchanged
ReorganizationExchangeOfEquityPercentageOfOrdinarySharesExchanged
|
1.00 | |
| CY2019Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.160849 | |
| CY2019Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.160849 | |
| CY2018Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
0 | |
| CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2018Q4 | etnb |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
890000 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.016 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.026 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y10M24D | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.732 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.031 | ||
| CY2019 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.21 | |
| CY2019 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
167000 | |
| CY2019 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1000 | |
| CY2019 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
30000 | |
| CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
283000 | |
| CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
573000 | |
| CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
325000 | |
| CY2018Q2 | us-gaap |
Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
|
The lease term was for 12 months and was amended in April 2019 to extend the lease term to April 2020. | |
| CY2018Q2 | etnb |
Operating Lease Monthly Rental Payments
OperatingLeaseMonthlyRentalPayments
|
4000 | |
| CY2018Q2 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P12M | |
| CY2019Q4 | us-gaap |
Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
|
The lease term is for 24 months, expiring in January 2022 | |
| CY2019Q4 | etnb |
Operating Lease Monthly Rental Payments
OperatingLeaseMonthlyRentalPayments
|
17500 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P24M | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
226000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
216000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
442000 | |
| CY2019 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
159000 | |
| us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
39000 | ||
| CY2019Q4 | etnb |
Capital Contribution Related To Extinguishment Of Preferred Stock Liability
CapitalContributionRelatedToExtinguishmentOfPreferredStockLiability
|
25600000 | |
| CY2018Q4 | etnb |
Temporary Equity Shares Issued And Outstanding
TemporaryEquitySharesIssuedAndOutstanding
|
24000000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
13788982 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
13788982 | |
| CY2019Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
2844193 | |
| CY2018Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
4924545 | |
| CY2019 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
389000 | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
108000 | ||
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.6180 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.8760 | |
| us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
48000 | ||
| CY2019 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
198000 | |
| us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
48000 | ||
| CY2019 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
20000 | |
| us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-20000 | ||
| CY2019 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
20000 | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-20000 | ||
| CY2019Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
3327000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
1966000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
451000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
20000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
10022000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3522000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
10022000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3502000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
20000 | |
| CY2019 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
6500000 | |
| CY2019 | us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized. | |
| CY2019Q4 | etnb |
Taxable Income Utilization Percentage
TaxableIncomeUtilizationPercentage
|
0.80 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
156000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-13095000 | |
| us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-3714000 | ||
| CY2019 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
6520000 | |
| us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
3502000 | ||
| CY2019 | etnb |
Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization
IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization
|
734000 | |
| CY2019 | etnb |
Income Tax Reconciliation Revaluation Of Convertible Preferred Share Liability
IncomeTaxReconciliationRevaluationOfConvertiblePreferredShareLiability
|
6039000 | |
| etnb |
Income Tax Reconciliation Revaluation Of Convertible Preferred Share Liability
IncomeTaxReconciliationRevaluationOfConvertiblePreferredShareLiability
|
226000 | ||
| CY2019 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
20000 | |
| us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
14000 | ||
| CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2019 | us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
39000 | |
| CY2019 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2844193 | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4924545 | ||
| CY2019Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
11000 | |
| CY2018Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
23000 | |
| CY2019Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9611000 | |
| CY2019Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8198000 | |
| CY2019Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3947000 | |
| CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4884000 | |
| CY2019Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19283000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18725000 | |
| CY2019Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-14525000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4887000 | |
| CY2019Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-2.58 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-30.63 | |
| CY2019Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-23.76 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-8.00 | |
| CY2018Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4408000 | |
| CY2018Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3786000 | |
| CY2018Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6968000 | |
| CY2018Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4638000 | |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4165000 | |
| CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7373000 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-7.59 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-6.81 | |
| CY2018Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-13.55 |
